Arab Journal of Gastroenterology
Volume 11, Issue 3 , Pages 167-170 , September 2010

Hepatic amyloidosis presenting as intrahepatic cholestasis and portal hypertension: Case series and review of literature

References 

  1. Levine RA. Amyloid disease of the liver: correlation of clinical, functional, and morphological features in forty seven patients. Am J Med. 1962;33:349–357
  2. Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology. 1997;25:118–121
  3. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis, clinical features and natural history in 98 patients. Medicine. 2003;82:291–298
  4. Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Gut. 1998;42:727–734
  5. Rockey DC, Durham NC. Striking cholestatic liver disease: a distinct manifestation of advanced primary amyloidosis. South Med J. 1999;92:236–241
  6. Liu CJ, Chien RN, Huang SF, Chiang JM. Severe intrahepatic cholestasis in an elderly patient with primary amyloidosis and colon adenocarcinoma. Chang Gung Med J. 2004;27:74–79
  7. Rubinow A, Koff RS, Cohen AS. Severe intrahepatic cholestasis in primary amyloidosis. A report of four cases and a review of the literature. Am J Med. 1978;64:937–946
  8. Harrison RF, Hawkins PN, Roche WR, Mac Mohan RF, Hubscher SG, Buckels JA. “Fragile” liver and massive hepatic hemorrhage due to hereditary amyloidosis. Gut. 1996;38:151–152
  9. Moller JM, Santoni-Rugiu E, Chabanova E, Logager V, Hansen AB, Thomsen HS. Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis. Acta Radiol. 2007;48:145–149
  10. Bion E, Brenard R, Pariente EA, Lebrec D, Degott C, Maitre F, et al. Sinusoidal portal hypertension in hepatic amyloidosis. Gut. 1991;32:227–230
  11. Itescu S. Hepatic amyloidosis an unusual cause of ascites and portal hypertension. Arch Intern Med. 1984;144:2257–2259
  12. Mainenti PP, Patrelli G, Lamanda R, Amalfi G, Castiglione F. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course. J Clin Gastroenterol. 1997;24:173–175
  13. Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2008;103:776–787
  14. Zeijen RN, Sels JP, Flendrig JA, Arends JW. Portal hypertension and intrahepatic cholestasis in hepatic amyloidosis. Neth J Med. 1991;38:257–261
  15. Dorde Culafic, Mirjana Perisic, Boricic I, Culafic-Vojinovic V, Vukcevic M. Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension. J Gastrointestinal Liver Dis. 2007;16:201–204
  16. Novak G, Westermark P, Wernerson A, Herlenius G, Sletten K, Ericzon B. Liver transplantation as a rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int. 2000;13:92–97
  17. Sandberg-Gertzen H, Ericzon B, Blomberg B. Primary amyloidosis with spontaneous splenic rupture, cholestasis and liver failure treated with emergency liver transplantation. Am J Gastroenterol. 1998;93:2254–2256
  18. Kumar KS, Lefkowitch J, Russo MW, Hesdorffer C, Kinkhabwala M, Kapur S, et al. Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. Gastroenterology. 2002;122:2026–2031
  19. Faust D, Akoglu B, Ristic G, Milovic V. Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis. Scand J Gastroenterol. 2008;43:375–379

PII: S1687-1979(10)00089-4

doi: 10.1016/j.ajg.2010.07.007

Arab Journal of Gastroenterology
Volume 11, Issue 3 , Pages 167-170 , September 2010

Article Tools

* Image Usage & Resolution